DURHAM — TeraRecon is building out its C-Suite.

The Durham-based company, which builds comprehensive medical imaging software using artificial intelligence (AI), has added two new members to its executive team: John Danahy as its chief revenue officer; and Martin Clancy as vice president of finance.

“As TeraRecon continues to grow and innovate, we want customers to enjoy increased value through the extension of AI-powered clinical intelligence,” said its president and CEO Jeff Sorenson, in a statement. “John and Martin bring an important next level of focus and expertise to our organization as we continue to elevate the customer experience.”

John Danahy

Danahy will lead TeraRecon’s customer-focused initiatives which includes global sales, service and support teams. He joins TeraRecon having been part of several digital healthcare transformations – from PACS and EMR technology companies, to venture-backed start up solution providers. Most recently, he was a founding leader of Salesforce.com’s Healthcare and Life Sciences vertical.

Clancy, meanwhile, will drive transformational aspects of the company’s financial operations and strategic planning. He formerly served as chief financial officer at DataCore Software for 10 years, and another 12 years in senior leadership roles at Citrix Systems.

“We are on the precipice of enormous growth over the next few years, following TeraRecon’s recent acquisition by Symphony AI,” Clancy said in a statement. “The combination of our unparalleled Advanced Visualization products with cutting edge AI solutions and world class support, puts us in an enviable position to offer differentiated patient care solutions for our customers and partners.”

Martin Clancy

In 2017, TeraRecon released a large algorithm marketplace, and a year later it launched a “results explorer,” which displays the AI-processed images in an interactive and efficient dashboard that gives physicians optimum control. TeraRecon’s full efforts have caught national attention, winning clearance from the U.S. Food and Drug Administration, and helping to lure some big clients, including the Cleveland Clinic, the Mayo Clinic, and several of Duke University’s and the University of North Carolina’s healthcare systems.

TeraRecon has more than 5,300 software installations in some 70 countries and stakes claim to several “first-of-its-kind” innovations. And in March, the company won two AI platform patents and was acquired by SymphonyAI, an operating group of leading business-to-business AI companies that brings with it a huge increase in resources and infrastructure.

Durham medical AI leader TeraRecon makes quick shift to COVID-19 imaging